ERBB2 and breast carcinoma: To analyze the binding characteristics of the 10 selected aptamers to HER2 receptors, we initially determined the expression levels of HER2 receptors on HER2-positive MDA-MB-453 and SK-BR-3, as well as HER2-negative MDA-MB-231 human breast cancer cell lines.